Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Intensive chemotherapy for acute myeloid leukemia (AML), when combined with broad-spectrum antibiotics, results in an imbalance of the gut microbiota. This dysbiosis can lead to pathological conditions and a higher incidence of complications (1).
It is an open-label phase I/II treatment trial ( Single Group Assignment) evaluating MaaT011 in 25 enrolled patients with Acute Myeloid Leukemia (AML) treated with intensive chemotherapy and antibiotics (1)
Dysbiosis correction by measure of microbiota diversity. The underlying rationale for this method is to address [dysbiosis](brain://ttq0yyIKokOTALuYxFnOeg/D…